Neuroscientific Biopharmaceuticals
Company Details
Status: Public
Employees: 1-10
Location:
Cottesloe, Western Australia, Australia
Type:
sample
Technology:
sample
sample
About: NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of neurodegenerative conditions with high unmet medical need. Therapeutic indications include Alzheimer’s Disease, Multiple Sclerosis, Glaucoma and Post-Covid Lung Fibrosis. The companies lead compound, EmtinB works by effectively slowing down the death of dying cells and regenerating damaged nerves and tissue fibres.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!

Neuroscientific Biopharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.